CHEMED CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 560.4 USD | -2.25% |
|
-6.66% | -4.16% |
| Apr. 26 | Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says | MT |
| Apr. 25 | Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,032 | 8,456 | 8,109 | 7,590 | 8,776 | 8,483 | - | - |
| Enterprise Value (EV) 1 | 7,116 | 8,456 | 8,109 | 7,590 | 8,776 | 7,843 | 7,432 | 6,923 |
| P/E ratio | 33 x | 27.3 x | 31.4 x | 30.5 x | 32.6 x | 26.8 x | 23.9 x | - |
| Yield | 0.28% | 0.25% | 0.26% | 0.29% | 0.27% | 0.29% | 0.31% | - |
| Capitalization / Revenue | 3.63 x | 4.07 x | 3.79 x | 3.56 x | 3.88 x | 3.49 x | 3.27 x | 3.09 x |
| EV / Revenue | 3.67 x | 4.07 x | 3.79 x | 3.56 x | 3.88 x | 3.22 x | 2.86 x | 2.52 x |
| EV / EBITDA | 20.3 x | 19 x | 17.6 x | 16.8 x | 19.4 x | 15.3 x | 13.5 x | 11.9 x |
| EV / FCF | 28.7 x | - | - | - | - | 20.9 x | 18.1 x | 13.6 x |
| FCF Yield | 3.49% | - | - | - | - | 4.79% | 5.53% | 7.35% |
| Price to Book | 9.65 x | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 16,009 | 15,876 | 15,328 | 14,870 | 15,008 | 15,137 | - | - |
| Reference price 2 | 439.3 | 532.6 | 529.0 | 510.4 | 584.8 | 560.4 | 560.4 | 560.4 |
| Announcement Date | 2/18/20 | 2/23/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,939 | 2,080 | 2,139 | 2,135 | 2,264 | 2,433 | 2,595 | 2,743 |
| EBITDA 1 | 350.9 | 444.8 | 461.4 | 452.3 | 451.9 | 512.5 | 549.9 | 580 |
| EBIT 1 | 301.4 | 389.7 | 404.9 | 412.1 | 393.8 | 421.9 | 468.8 | 524.4 |
| Operating Margin | 15.55% | 18.74% | 18.93% | 19.3% | 17.39% | 17.34% | 18.07% | 19.11% |
| Earnings before Tax (EBT) 1 | 261.6 | 396 | 350.3 | 329.7 | 350.4 | 408.9 | 456.7 | - |
| Net income 1 | 219.9 | 319.5 | 268.6 | 249.6 | 272.5 | 318.6 | 356.2 | - |
| Net margin | 11.34% | 15.36% | 12.55% | 11.69% | 12.03% | 13.09% | 13.73% | - |
| EPS 2 | 13.31 | 19.48 | 16.85 | 16.72 | 17.93 | 20.94 | 23.49 | - |
| Free Cash Flow 1 | 248.2 | - | - | - | - | 376 | 411 | 509 |
| FCF margin | 12.8% | - | - | - | - | 15.45% | 15.84% | 18.56% |
| FCF Conversion (EBITDA) | 70.73% | - | - | - | - | 73.37% | 74.75% | 87.76% |
| FCF Conversion (Net income) | 112.87% | - | - | - | - | 118.02% | 115.37% | - |
| Dividend per Share 2 | 1.240 | 1.320 | 1.400 | 1.480 | 1.560 | 1.640 | 1.722 | - |
| Announcement Date | 2/18/20 | 2/23/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 538.7 | 541 | 530.5 | 531.3 | 526.5 | 546.7 | 560.2 | 553.8 | 564.5 | 585.9 | 589.2 | 601.8 | 613.9 | 638.5 | 637.3 |
| EBITDA 1 | 119.4 | 122.6 | 110.2 | 110.9 | 108.7 | 122.5 | 111 | 109.1 | 115.8 | 139.6 | 114.6 | 122.8 | 128.8 | 143.1 | 126.8 |
| EBIT 1 | 104.3 | 112 | 101.8 | 103.1 | 99.58 | 107.6 | 98.84 | 94.84 | 98.55 | 125.3 | 92.83 | 101.5 | 107.8 | 121.8 | 107.1 |
| Operating Margin | 19.36% | 20.71% | 19.2% | 19.41% | 18.92% | 19.68% | 17.64% | 17.13% | 17.46% | 21.39% | 15.75% | 16.86% | 17.56% | 19.07% | 16.81% |
| Earnings before Tax (EBT) 1 | 95.42 | 96.13 | 84.7 | 86.11 | 76.47 | 82.4 | 71.16 | 70.34 | 93.26 | 115.6 | 84.48 | 102.6 | 101.8 | 112.9 | - |
| Net income 1 | 72 | 74.62 | 64.17 | 66.46 | 56.87 | 62.13 | 54.12 | 53.38 | 74.96 | 90.05 | 65.02 | 77.04 | 80.28 | 89.87 | 83.25 |
| Net margin | 13.37% | 13.79% | 12.09% | 12.51% | 10.8% | 11.36% | 9.66% | 9.64% | 13.28% | 15.37% | 11.03% | 12.8% | 13.08% | 14.08% | 13.06% |
| EPS 2 | 4.550 | 4.810 | 4.220 | 4.400 | 3.780 | 4.130 | 3.580 | 3.510 | 4.930 | 5.900 | 4.240 | 5.045 | 5.265 | 5.895 | 5.450 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/28/21 | 2/24/22 | 4/26/22 | 7/27/22 | 10/31/22 | 2/23/23 | 4/26/23 | 7/26/23 | 10/25/23 | 2/27/24 | 4/24/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 83.8 | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | - | - | 640 | 1,051 | 1,560 |
| Leverage (Debt/EBITDA) | 0.2389 x | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 248 | - | - | - | - | 376 | 411 | 509 |
| ROE (net income / shareholders' equity) | 33.4% | 39.3% | 35.2% | 41.9% | 32.4% | 30.6% | - | - |
| ROA (Net income/ Total Assets) | 19.6% | - | - | - | - | - | - | - |
| Assets 1 | 1,122 | - | - | - | - | - | - | - |
| Book Value Per Share | 45.50 | - | - | - | - | - | - | - |
| Cash Flow per Share 2 | 18.20 | 29.80 | 19.40 | 20.50 | 21.70 | 25.10 | 28.30 | - |
| Capex 1 | 53 | - | - | - | - | 58 | 61 | - |
| Capex / Sales | 2.74% | - | - | - | - | 2.38% | 2.35% | - |
| Announcement Date | 2/18/20 | 2/23/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
560.4
USD
Average target price
688.8
USD
Spread / Average Target
+22.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.16% | 8.48B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -3.97% | 11.66B | |
| -1.42% | 11.72B | |
| -31.75% | 11.77B |
- Stock Market
- Equities
- CHE Stock
- Financials Chemed Corporation
